Skip to menu Skip to content Skip to footer

1999

Conference Publication

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.

Ramm, G.A., Murphy, T.L., Fanning, P.A., Clouston, A.D., Anderson, G.J. and Crawford, D.H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.. 50th Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, 5-9 November 1999. Hoboken, NJ, United States: John Wiley & Sons.

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.

1998

Conference Publication

Spur cell anemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.

Pascoe, A, Kerlin, P, Steadman, C, Clouston, A, Powell, L, Jazwinska, E, Lynch, S and Strong, R (1998). Spur cell anemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.. PHILADELPHIA: W B SAUNDERS CO. doi: 10.1016/S0016-5085(98)85357-2

Spur cell anemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.

1998

Conference Publication

Human liver-derived leucocytes express FasL and immunomodulatory cytokines and induce apoptosis of activated allogeneic T cells

Jonsson, J. R., Edwards-Smith, C. J., Hogan, P. G., Morotomi, Y., Clouston, A. D., Lynch, S. V., Strong, R. W. and Powell, E. E. (1998). Human liver-derived leucocytes express FasL and immunomodulatory cytokines and induce apoptosis of activated allogeneic T cells. 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 6-10 November 1998. Hoboken, NJ, United States: John Wiley & Sons.

Human liver-derived leucocytes express FasL and immunomodulatory cytokines and induce apoptosis of activated allogeneic T cells

1997

Conference Publication

The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver

Ramm, G.A., Ooi, L. L. P. J., Gotley, D. C., Clouston, A. D., Bridle, K. R. and Crawford, D. H. G. (1997). The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver. 8th International Symposium on the Cells of the Hepatic Sinusoid, Bordeaux, France, 1-5 September 1996. Leiden, Netherlands: Kupffer Cell Foundation.

The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver

1997

Conference Publication

Expression of Fas/FasL and bcl-2 in normal human liver derived leucocytes

Jonsson, J. R., EdwardsSmith, C. J., Morotomi, Y., Hogan, P. G., Clouston, A. D., Lynch, S. V., Strong, R. W. and Powell, E. E. (1997). Expression of Fas/FasL and bcl-2 in normal human liver derived leucocytes. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons.

Expression of Fas/FasL and bcl-2 in normal human liver derived leucocytes